| Rheumatoid Arthritis |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.98 |
| Statins |
0 |
0.72 |
| Lipids Management |
0 |
0.7 |
| Arthritis |
0 |
0.4 |
| Biomarker |
0 |
0.32 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.32 |
| Cardiometabolic Risk Factors |
0 |
0.3 |
| Biologic Therapy |
0 |
0.24 |
| Heart |
0 |
0.24 |
| Cardiovascular disease |
0 |
0.99 |
| Clinical Guidelines |
0 |
0.16 |
| Medical Life |
0 |
0.14 |
| Atherosclerosis |
0 |
0.08 |
| Autoimmune Disease |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| CT Scan |
0 |
0.08 |
| Cytokines |
0 |
0.08 |
| Fatigue |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Immunotherapy |
0 |
0.08 |
| Jobs |
0 |
0.08 |
| Lupus |
0 |
0.08 |
| Match |
0 |
0.08 |
| New York |
0 |
0.08 |
| Patient History |
0 |
0.08 |
| Remission |
0 |
0.08 |
| Tumor |
0 |
0.08 |
| Obesity |
0 |
0.07 |
| Psoriasis |
0 |
0.07 |
| Systemic Lupus Erythematosus |
0 |
0.07 |